Intake of soy products and soy isoflavones in relation to ovarian reserve

被引:5
|
作者
Mitsunami, Makiko [1 ]
Minguez-Alarcon, Lidia
Florio, Andrea A. [1 ]
Wang, Siwen [1 ]
Attaman, Jill A. [5 ,6 ]
Souter, Irene [5 ,6 ]
Hauser, Russ [2 ,3 ,5 ,6 ]
Chavarro, Jorge E. [1 ,2 ,4 ,5 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Massachusetts Gen Hosp, Fertil Ctr, Vincent Dept Obstet & Gynecol, Boston, MA USA
基金
美国国家卫生研究院;
关键词
Soy intake; ovarian reserve; antral follicle count; reproductive medicine; IN-VITRO FERTILIZATION; FOOD FREQUENCY QUESTIONNAIRE; NEONATAL EXPOSURE; SEMEN QUALITY; WOMEN; PHYTOESTROGENS; VALIDITY; HORMONE; REPRODUCIBILITY; STIMULATION;
D O I
10.1016/j.fertnstert.2023.02.039
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate the association between intake of soy food and isoflavone with ovarian reserve. Previous studies suggest on the relationship between soy intake and human fertility are inconsistent. Some clinical studies suggest that soy and phytoestrogens may not be deleterious to reproduction and may even be beneficial in couples undergoing infertility treatment. However, no studies have evaluated the relationship between soy or isoflavone intake with markers of ovarian reserve other than follicle-stimulating hormone (FSH).Design: Cross-sectional study.Setting: An academic fertility center.Patient(s): Patients presenting to an academic fertility center between 2007 and 2019 were invited to participate in the Environment and Reproductive Health Study. Intervention(s): Six hundred and sixty seven participants reported their soy food intake and had an antral follicle count (AFC) assess-ment. Intake of 15 soy-based foods during the previous 3 months was obtained at baseline and intake of isoflavone was estimated. Participants were divided into 5 groups based on soy food and isoflavone intake considering those who did not consume soy as the reference group. Main Outcome Measure(s): Ovarian reserve was assessed using AFC as the primary outcome measure, with antimueurollerian hormone (AMH) and FSH as secondary outcome measures. The AFC was measured on the third day of the menstrual cycle. Moreover, FSH and AMH levels were measured in blood samples obtained on the third day and the follicular phase of the menstrual cycle. To evaluate the association between soy intake and ovarian reserve, we used Poisson regression models for AFC and quantile regression models for AMH and day 3 FSH levels by adjusting for confounders.Result(s): Participants had a median age of 35.0 years. The median intake of soy was 0.09 servings/day and isoflavones was 1.78 mg/ day. Moreover, AFC, AMH, and FSH were unrelated to soy intake in crude analyses. We found no association between soy food intake with AFC or day 3 FSH level in multivariable models. However, participants in the highest category of soy food intake had significantly low AMH levels (-1.16, 95% confidence interval:-1.92,-0.41). Soy intake had no association with AFC, AMH, or FSH in sensitivity analyses that included using different cutoff points of soy intake, excluding participants in the highest 2.5 percentile of intake, and additional statistical adjustment for dietary patterns.Conclusion(s): The results of this study are not consistent with a strong positive or inverse association of soy or isoflavone intakes within the observed range of intake, which substantially overlaps with that in the general population of the United States as well as the ovarian reserve among individuals presenting to fertility centers. (Fertil Steril (R) 2023;119:1017-29.(c) 2023 by American Society for Reproductive Medicine.)
引用
收藏
页码:1017 / 1029
页数:13
相关论文
共 50 条
  • [21] The effects of soy protein and soy isoflavones intake on chronic kidney disease: a systematic review and meta-analysis
    Yu, Zhixiang
    Xu, Yongxing
    Liu, Juan
    Yang, Qing
    Lu, Yangyang
    Zhen, Zhangrui
    Gao, Yuehua
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, : 1533 - 1553
  • [22] Role of soy isoflavones in the hypotriglyceridemic effect of soy protein in the rat
    Demonty, I
    Lamarche, B
    Deshaies, Y
    Jacques, H
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2002, 13 (11): : 671 - 677
  • [23] Effects of Soy Protein and Isoflavones Intake on HDL Metabolism in Asian Populations
    Yanai, Hidekatsu
    Katsuyama, Hisayuki
    Hamasaki, Hidetaka
    Abe, Shinichi
    Tada, Norio
    Sako, Akahito
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2014, 4 (03) : 51 - 55
  • [24] Soy Isoflavones and Gastrointestinal Health
    Layla Al-Nakkash
    Aaron Kubinski
    Current Nutrition Reports, 2020, 9 : 193 - 201
  • [25] The effects of soy isoflavones on obesity
    Orgaard, Anne
    Jensen, Lotte
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 233 (09) : 1066 - 1080
  • [26] Soy isoflavones: Are they useful in menopause?
    Vincent, A
    Fitzpatrick, LA
    MAYO CLINIC PROCEEDINGS, 2000, 75 (11) : 1174 - 1184
  • [27] Impact of soy isoflavones on the epigenome
    Gerhauser, Clarissa
    Pudenz, Maria
    Krug, Anna Lena
    TOXICOLOGY LETTERS, 2016, 258 : S5 - S5
  • [28] Soy isoflavones: hope or hype?
    Fitzpatrick, LA
    MATURITAS, 2003, 44 : S21 - S29
  • [29] Soy, isoflavones and breast cancer
    Lecerf, Jean-Michel
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (10): : 302 - 308
  • [30] Soy isoflavones and cancer prevention
    Sarkar, FH
    Li, YW
    CANCER INVESTIGATION, 2003, 21 (05) : 744 - 757